EuroGRAFT
Action number CA17138 COST

Latest Events

5th International Chronic Graft-versus-Host Disease Symposium

Zagreb, Croatia
April 15-16th 2021

Chairs: Steven Z. Pavletić (USA), Daniel Wolff (Germany), Kirk Schultz (Canada), Radovan Vrhovac (Croatia), and Dražen Pulanić (Croatia)

Topics: Highlights from the newest 2020 NIH cGvHD consensus project, Chronic GvHD progress review

It is our great pleasure to invite you to the 5th International Chronic Graft-versus-Host Disease Symposium that will be organized in Zagreb, Croatia, from April 15-16th, 2021.

Depending on COVID-19 epidemiology situation, the symposium will be organized mostly or (very likely) completely as a virtual meeting.

Chronic graft-versus-host disease (cGvHD) has been recognized as a major long-term complication after allogeneic stem cell transplantation (alloHSCT) and an increasing problem due to a growing number of long term survivors following alloHSCT. This 5th cGvHD International Symposium will be divided in several sections: 1) Highlights from the newest 2020 NIH cGvHD consensus project, 2) Chronic GvHD progress review 3) Interactive cases for Hematology Residents and young Hematologists, and 4) Future projects.

Download event flyer

Working Group Meeting

The next working group meeting of the COST Action EUROGRAFT (CA17138) will be held in the final week of September 2021 in Gdansk, Poland.

Confirmed dates to be released shortly.

 

STSM Report: Joanna Wielińska

STSM Reports

I am Joanna Wielińska, a PhD student in Professor Katarzyna Bogunia-Kubik’s Laboratory of Clinical Immunogenetics and Pharmacogenetics at the Hirszfeld Institute of Immunology and Experimental Therapy in Wroclaw, Poland.

STSM Report: Piotr Łacina

STSM Reports

My name is Piotr Łacina and I am a PhD student supervised by Professor Katarzyna Bogunia-Kubik at Laboratory of Clinical Immunogenetics and Pharmacogenetics of the Hirszfeld Institute of Immunology and Experimental Therapy in Wroclaw, Poland.

STSM Report: Nathaniel Saidu

STSM Reports

How molecular biology and pharmacogenetics can help to understand the immune system’s behavior during the treatment of cGVHD with immunotherapy: the role of PD-L1, Torquetenovirus and of the assessment of tyrosine kinase inhibitors plasma levels.

STSM Report: Francesca Perutelli

STSM Reports

I am Francesca Perutelli and I am a medical doctor at the Department of Haematology of the University of Pisa, Italy. In January went to Newcastle for a 2-month STSM for Working Group 2 on ‘Molecular and Cellular Biomarkers of Chronic Graft versus Host Disease (cGvHD)’.

Categories

Are you interested
in taking part?

The COST Action EUROGRAFT welcomes research-active scientists working in the field. There are many ways to get involved.

Get involved

Get involved

Do you have a question?

If you have any questions or would like to know more about the project, simply connect with us and we’ll be happy to talk to you.